Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoCloud-9 Combined With Carboplatin vs Standard of Care in Recurrent Glioblastoma
NCT05902169Phase 3Recruiting
- Sponsor
- CarThera
- Start
- Jan 2024
- Primary completion
- Jan 2028
- Countries
- 11
01
Overview
A Phase 3 trial of carboplatin in glioblastoma (GBM), sponsored by CarThera. Started Jan 2024; status: recruiting.
02
Drugs
carboplatin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT05902169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05902169.